Back to results
US 12,016,844 B2Granted
Mammary tumor virus suppression
AssigneeVirago Vax Inc.
InventorSophie Bartsich
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of treating a patient exposed to MTV. Also disclosed is a purified cDNA encoding an MTV transition protein peptide chain. Also disclosed is a vaccine containing an MTV transition protein. A further version of the invention is a vaccine comprising MTV polypeptides coupled to a carrier protein. MTV may be treated by providing an MTV vaccine with an MTV transition protein; and, administering said vaccine. In further instances, the MTV vaccine is administered with an antiretroviral medication.
Claims16
A method, comprising:
- administering an antiretroviral medication to a patient the antiretroviral medication being a protease inhibitor;
- and
- administering a pharmaceutical composition containing an MTV protein of SEQ ID:
- 02 and an adjuvant in conjunction with the antiretroviral medication.
1 more element
A method, comprising:
- testing a patient for the presence of MTV;
- confirming the presence of MTV in the patient;
- administering a protease inhibitor to the patient;
- and
- administering a pharmaceutical preparation containing an MTV protein of SEQID:02 and an adjuvant in conjunction with the protease inhibitor.
2 more elements
A method, comprising:
- administering to a person with MTV exposure a pharmaceutical composition containing a transition protein of SEQID:02 and an adjuvant;
- and
- administering an antiretroviral medication.
Dependencies are inferred from the claim text.